Our new @zeiss_micro Axio Zoom v.16 with Apotome captures confocal-like images of macroscopic objects. Paper fibers stained with safranin and imaged at 260x total magnification with standard widefield and then with Apotome + deconvolution. 40 x 1 um Z-stacks.
Doug Olsen's blood cancer returned after 5yrs in remission... he had 2 options: a bone marrow transplant or a highly experimental therapy that really only been done in mice. 10yrs later he's still cancer-free. This is CAR-T #CellTherapy
Read more: https://t.co/iJSaayx93i
South Australian COVID-19 update 22/12/21. For more information, go to https://t.co/mYnZsGpayo or contact the South Australia COVID-19 Information Line on 1800 253 787.
We propose that tumour-associated neo-differentiation (TAND) led by CAFs is a targetable aspect of the microenvironment and that understanding it will help develop a new generation of cancer therapies. @CCB_Research@unisaresearch@CentralAdlLHN
Pleased to share a new opinion piece @TrendsCellBio in which Marina Kochetkova and I propose a fresh development-informed perspective on the tumour microenvironment that places cancer-associated fibroblasts (CAFs) at its heart. https://t.co/Oc4ujZBRhQ
Congratulations to former MedTech Actuator Origin contestant @OminiWell on becoming a finalist in the 2021 #SAScienceAwards Innovator of the Year! More on Ominiwell at https://t.co/G2md82q4hf
@ChiaLinChien@ChiaChiChien
Imagine if you could trial a drug on test cells identical to your own before subjecting yourself to the treatment. @OminiWell is a SA business founded on this innovative concept, with incredible R&D going into making this idea a reality for cancer patients.
#SAScienceAwards
Participating in a CRC-P allowed SA company Miniprobes to access vital resources and accelerate their R&D process through collab with @UniofAdelaide and industry partners @meatlivestock.
Could your business benefit from this @IndustryGovAu program? Visit: https://t.co/lbTnfUqQU8
"The MedTech Actuator Menzies Scholarship allowed Ominiwell to access intensive training & understand the reality of commercialising a medical device." – Dr @ChiaChiChien, @OminiWell, MedTech Actuator Menzies Scholar.
Apply to join the next cohort today – https://t.co/00carcwC4R
For more than 40 years, the @MenziesFdation has supported leadership & entrepreneurship. From Sydney is Menzies Foundation board member @tony_surtees to launch their report Spinning out: Supporting science start-ups in Australia https://t.co/8c4raYUDpy